The Latest Breaking News on Alzheimer’s study in Boston looking at possible treatment to prevent the disease

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.

Newly approved Leqembi promises to slow the disease, but patients will have to consider risks and reimbursement

A drug that has been shown to slow the early stages of Alzheimer’s disease has been approved by US health officials.

US health officials have approved a drug that has been shown to slow the early stages of Alzheimer’s disease.

A new Alzheimer’s drug is hitting the market with experts voicing a lot of caution

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized…

The FDA on Friday authorized the use of the Alzheimer’s drug lecanemab, the first drug clearly shown to slow the progress of the debilitating brain disease.

Washington (AFP) - The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.